^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners

TEST:
ATRX Rabbit Polyclonal Antibody

Company:
Roche
Type:
Laboratory Developed Test
Related tests:
Evidence

News

1year
Roche launches two new antibodies to identify key clinical mutations in patients with brain cancer (Roche Press Release)
"Roche...announced today the launch of the IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody and the ATRX Rabbit Polyclonal Antibody to identify mutation status in patients diagnosed with brain cancer....The two tests are now available in the US. They will likely be available in other non-CE markets later this year and in countries that accept the CE mark in 2024."
Launch US
|
ATRX Rabbit Polyclonal Antibody • IDH1 R132H (MRQ-67) Rabbit Monoclonal Primary Antibody